MDB · sample dossier
MDB
57/100
OutdatedGenerated Aug 30, 2026 · 11:04 PM UTC · 67 days ago
This copy is frozen (Aug 30). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierMDB
EquityPublic company
Decision context
Recommendation
Balanced between solid Momentum (97/100) and constrained Valuation (20/100).
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive thesis & key metrics
Executive Investment Thesis
MDB is a $35.92B market cap enterprise trading at $446.62 with a gross margin of 72.0% and positive free cash flow per share of $6.44 (vendor-reported TTM ratio). Top-line expansion remains robust with 25.2% YoY revenue growth, 110.9% YoY EPS growth, and minimal balance sheet leverage at a Debt/Equity of 0.02. However, GAAP profitability remains negative with a net margin of -1.1%, ROA of -1.8%, and extreme valuation multiples including a P/E ratio of -1240.61 and EV/EBITDA of -418.89.
Key Metrics to Watch
What changed recently
No material changes found in the last 30 days.
Why this rating
Score 57 · Hold
Data through
OutdatedApr 30, 2026
Momentum 97/100 — price trend leads the profile.
Re-evaluate if
- Severe accounting disclosures (auditor / restatement / going concern) in SEC filings
- Net margin falls below -0.9% (was -1.1%)
- Piotroski F-Score falls below 5
Trim / reconsider if
- ROA falls below -1.2% (was -1.8%)
- Net Margin falls below -1.1%
- Debt to Equity increases above 0.02
Think of these dollars as a map of our value estimate for Hold — helpful context, not a reason to override the view.
A Calmer Look · Devil's Advocate
The prevailing consensus dangerously excuses negative GAAP profitability by over-relying on free cash flow per share of $6.44 and robust gross margins of 72.0%.
May be overlooked
The market debate focuses on non-GAAP free cash flow while ignoring that GAAP net margin is negative at -1.1% and ROA is -1.8%.
Consensus minimizes the Form 10-K disclosure regarding deficiencies in internal controls over financial reporting that could trigger restatements.
The reliance on 25.2% revenue growth overlooks how stock-based compensation likely drives the divergence between positive FCF per share of $6.44 and negative GAAP EPS.
Expectations look stretched
Extrapolating a 37.1% 1-month price surge to justify an extreme valuation at P/B of 12.3 and P/E of -1240.6.
Assuming sustained multiple expansion when DA Davidson raised the price target to $465 based on a fragile assumption that revenue growth will sustain above 25.2% YoY.
Treating a Piotroski F-score of 5/9 as strong fundamental health despite persistent negative operational earnings.
Revenue Growth YoY drops below 25.2%
Revenue Growth YoY drops below 25.2%
Monitor These Triggers
3 Checkpoints · Next PrintRevenue Growth YoY (current baseline: 25.2%)
Market context
Snapshot returns at report publication
1 month
+37.1%
3 months
+33.1%
6 months
+36.0%
1 year
—
At a Glance
A large company is on a steady trend at unprofitable earnings.
Top Holders
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full MDB dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.